These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24729189)

  • 1. Nature-inspired nanoformulations for contrast-enhanced in vivo MR imaging of macrophages.
    Sigalov AB
    Contrast Media Mol Imaging; 2014; 9(5):372-82. PubMed ID: 24729189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Magnetic Resonance Imaging of Atherosclerosis in Apolipoprotein E Knockout Mouse Model Using Macrophage-Targeted Gadolinium-Containing Synthetic Lipopeptide Nanoparticles.
    Shen ZT; Zheng S; Gounis MJ; Sigalov AB
    PLoS One; 2015; 10(11):e0143453. PubMed ID: 26569115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporation of an apoE-derived lipopeptide in high-density lipoprotein MRI contrast agents for enhanced imaging of macrophages in atherosclerosis.
    Chen W; Vucic E; Leupold E; Mulder WJ; Cormode DP; Briley-Saebo KC; Barazza A; Fisher EA; Dathe M; Fayad ZA
    Contrast Media Mol Imaging; 2008; 3(6):233-42. PubMed ID: 19072768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen-specific peptide conjugated HDL nanoparticles as MRI contrast agent to evaluate compositional changes in atherosclerotic plaque regression.
    Chen W; Cormode DP; Vengrenyuk Y; Herranz B; Feig JE; Klink A; Mulder WJ; Fisher EA; Fayad ZA
    JACC Cardiovasc Imaging; 2013 Mar; 6(3):373-84. PubMed ID: 23433925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of synthetic high density lipoprotein (HDL) contrast agents for MR imaging of atherosclerosis.
    Cormode DP; Chandrasekar R; Delshad A; Briley-Saebo KC; Calcagno C; Barazza A; Mulder WJ; Fisher EA; Fayad ZA
    Bioconjug Chem; 2009 May; 20(5):937-43. PubMed ID: 19378935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes.
    Briley-Saebo KC; Shaw PX; Mulder WJ; Choi SH; Vucic E; Aguinaldo JG; Witztum JL; Fuster V; Tsimikas S; Fayad ZA
    Circulation; 2008 Jun; 117(25):3206-15. PubMed ID: 18541740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.
    Pérez-Medina C; Binderup T; Lobatto ME; Tang J; Calcagno C; Giesen L; Wessel CH; Witjes J; Ishino S; Baxter S; Zhao Y; Ramachandran S; Eldib M; Sánchez-Gaytán BL; Robson PM; Bini J; Granada JF; Fish KM; Stroes ES; Duivenvoorden R; Tsimikas S; Lewis JS; Reiner T; Fuster V; Kjær A; Fisher EA; Fayad ZA; Mulder WJ
    JACC Cardiovasc Imaging; 2016 Aug; 9(8):950-61. PubMed ID: 27236528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant high-density lipoprotein nanoparticles containing gadolinium-labeled cholesterol for morphologic and functional magnetic resonance imaging of the liver.
    Rui M; Guo W; Ding Q; Wei X; Xu J; Xu Y
    Int J Nanomedicine; 2012; 7():3751-68. PubMed ID: 22888232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
    Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
    Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-inflammatory drug evaluation in ApoE-/- mice by ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
    Sigovan M; Kaye E; Lancelot E; Corot C; Provost N; Majd Z; Breisse M; Canet-Soulas E
    Invest Radiol; 2012 Sep; 47(9):546-52. PubMed ID: 22864378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadolinium-containing phosphatidylserine liposomes for molecular imaging of atherosclerosis.
    Maiseyeu A; Mihai G; Kampfrath T; Simonetti OP; Sen CK; Roy S; Rajagopalan S; Parthasarathy S
    J Lipid Res; 2009 Nov; 50(11):2157-63. PubMed ID: 19017616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradable synthetic high-density lipoprotein nanoparticles for atherosclerosis.
    Marrache S; Dhar S
    Proc Natl Acad Sci U S A; 2013 Jun; 110(23):9445-50. PubMed ID: 23671083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadolinium(III)-gold nanorods for MRI and photoacoustic imaging dual-modality detection of macrophages in atherosclerotic inflammation.
    Qin H; Zhou T; Yang S; Chen Q; Xing D
    Nanomedicine (Lond); 2013 Oct; 8(10):1611-24. PubMed ID: 23351094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging.
    Ouimet T; Lancelot E; Hyafil F; Rienzo M; Deux F; Lemaître M; Duquesnoy S; Garot J; Roques BP; Michel JB; Corot C; Ballet S
    Mol Pharm; 2012 Apr; 9(4):850-61. PubMed ID: 22352457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An ApoA-I mimetic peptide high-density-lipoprotein-based MRI contrast agent for atherosclerotic plaque composition detection.
    Cormode DP; Briley-Saebo KC; Mulder WJ; Aguinaldo JG; Barazza A; Ma Y; Fisher EA; Fayad ZA
    Small; 2008 Sep; 4(9):1437-44. PubMed ID: 18712752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRI.
    von zur Muhlen C; Fink-Petri A; Salaklang J; Paul D; Neudorfer I; Berti V; Merkle A; Peter K; Bode C; von Elverfeldt D
    Contrast Media Mol Imaging; 2010; 5(5):268-75. PubMed ID: 20973112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles.
    Cormode DP; Roessl E; Thran A; Skajaa T; Gordon RE; Schlomka JP; Fuster V; Fisher EA; Mulder WJ; Proksa R; Fayad ZA
    Radiology; 2010 Sep; 256(3):774-82. PubMed ID: 20668118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo detection of oxidation-specific epitopes in atherosclerotic lesions using biocompatible manganese molecular magnetic imaging probes.
    Briley-Saebo KC; Nguyen TH; Saeboe AM; Cho YS; Ryu SK; Volkova ER; Dickson S; Leibundgut G; Wiesner P; Green S; Casanada F; Miller YI; Shaw W; Witztum JL; Fayad ZA; Tsimikas S
    J Am Coll Cardiol; 2012 Feb; 59(6):616-26. PubMed ID: 22300697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraperitoneal injection improves the uptake of nanoparticle-labeled high-density lipoprotein to atherosclerotic plaques compared with intravenous injection: a multimodal imaging study in ApoE knockout mice.
    Jung C; Kaul MG; Bruns OT; Dučić T; Freund B; Heine M; Reimer R; Meents A; Salmen SC; Weller H; Nielsen P; Adam G; Heeren J; Ittrich H
    Circ Cardiovasc Imaging; 2014 Mar; 7(2):303-11. PubMed ID: 24357264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage-specific lipid-based nanoparticles improve cardiac magnetic resonance detection and characterization of human atherosclerosis.
    Lipinski MJ; Frias JC; Amirbekian V; Briley-Saebo KC; Mani V; Samber D; Abbate A; Aguinaldo JG; Massey D; Fuster V; Vetrovec GW; Fayad ZA
    JACC Cardiovasc Imaging; 2009 May; 2(5):637-47. PubMed ID: 19442953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.